Barclays Initiates Coverage on Hill-Rom (NYSE:HRC)

Share on StockTwits

Barclays began coverage on shares of Hill-Rom (NYSE:HRC) in a research report issued on Monday, October 15th, Marketbeat Ratings reports. The firm set an “equal weight” rating and a $95.00 price target on the medical technology company’s stock. Barclays’ target price would suggest a potential downside of 2.21% from the company’s previous close.

A number of other research analysts have also recently issued reports on the company. Northcoast Research reissued a “buy” rating and set a $104.00 price objective on shares of Hill-Rom in a report on Tuesday, July 31st. Zacks Investment Research cut Hill-Rom from a “buy” rating to a “hold” rating in a report on Wednesday, August 1st. ValuEngine raised Hill-Rom from a “hold” rating to a “buy” rating in a report on Tuesday, July 31st. KeyCorp lifted their price objective on Hill-Rom from $97.00 to $115.00 and gave the company an “overweight” rating in a report on Tuesday, July 17th. Finally, Raymond James lifted their price objective on Hill-Rom from $97.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, July 30th. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $100.00.

Shares of Hill-Rom stock traded down $0.87 during midday trading on Monday, hitting $97.15. The company had a trading volume of 501,078 shares, compared to its average volume of 701,448. The company has a market cap of $6.45 billion, a price-to-earnings ratio of 20.45, a PEG ratio of 1.34 and a beta of 0.90. The company has a current ratio of 1.74, a quick ratio of 1.30 and a debt-to-equity ratio of 1.11. Hill-Rom has a 1-year low of $75.68 and a 1-year high of $98.96.

Hill-Rom (NYSE:HRC) last issued its earnings results on Friday, November 2nd. The medical technology company reported $1.63 EPS for the quarter, topping the consensus estimate of $1.51 by $0.12. The firm had revenue of $759.20 million during the quarter, compared to analysts’ expectations of $750.90 million. Hill-Rom had a return on equity of 21.10% and a net margin of 8.86%. Hill-Rom’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period last year, the business earned $1.32 earnings per share. As a group, research analysts forecast that Hill-Rom will post 5.13 earnings per share for the current fiscal year.

Several institutional investors have recently bought and sold shares of HRC. Bank of Montreal Can acquired a new position in shares of Hill-Rom during the 2nd quarter worth about $148,571,000. Amundi Pioneer Asset Management Inc. grew its position in shares of Hill-Rom by 10,137.2% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 392,289 shares of the medical technology company’s stock valued at $34,128,000 after purchasing an additional 388,457 shares during the period. Jennison Associates LLC grew its position in shares of Hill-Rom by 47.0% in the 3rd quarter. Jennison Associates LLC now owns 978,335 shares of the medical technology company’s stock valued at $92,355,000 after purchasing an additional 312,771 shares during the period. BTIM Corp. acquired a new position in shares of Hill-Rom in the 2nd quarter valued at approximately $19,352,000. Finally, Millennium Management LLC grew its position in shares of Hill-Rom by 32.3% in the 2nd quarter. Millennium Management LLC now owns 583,635 shares of the medical technology company’s stock valued at $50,975,000 after purchasing an additional 142,654 shares during the period. Institutional investors own 80.65% of the company’s stock.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Further Reading: How does inflation affect different investments?

Analyst Recommendations for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.